05.30.26 -- Insufficient Vendor Data Is Hamstringing Single-Use Technology Adoption

I never thought I’d develop strong feelings about plastic bags and tubing, but here we are. Recently, during our April Live event on closing the adoption gap for advanced single-use technologies (SUT), I had the chance to discuss the factors underlying this steep adoption curve with experts Katrina Cordovado, Joshua Nelson, Ph.D., and Paul Priebe.

What I took away from this event is that the single-use adoption gap is due in large part to the insufficiency and limited usability of vendor data packages, which inadvertently passes the validation burden to end users.

But what exactly is the extent of this validation burden? While we didn’t have enough time to cover this in depth during the hour, I was lucky enough to have all three panelists join me on the “Better Biopharma” podcast after the event to discuss the validation challenges facing single-use adopters. They also answered some audience questions we didn’t get to live.

I’d recommend watching the event recording first to establish some context before listening to the companion podcast, but don’t let me tell you what to do!

Before you go, check out some selected content from our partners below!

Tyler Menichiello                       
Chief Editor, Bioprocess Online

Cytiva explains how low ash, hardened, and ashless filter papers support accurate quantitative analysis, helping labs choose the right grade for reliable results.

Charter Medical assists a cell therapy developer in streamlining cryopreserved cell bank filling, accelerating scale‑up, and reducing cleanroom burden.

Ensorcell explores sterile connection choices and the impact they have on flexibility, risk, and efficiency in modern biomanufacturing as production models continue to evolve.

Single Use Support shows how flexible process solutions help teams manage volatility, scale confidently, and protect production continuity with resilient strategies.

Grand River Aseptic Manufacturing smart equipment partnerships and adaptable filling strategies improve Annex 1 compliance and accelerate confident commercialization.

August Bioservices delivers one-stop sterile injectable fill/finish capacity, combining modern filling technologies and scalable expansion to support growth.

Entegris introduces a closed, sterile approach to cell harvest and separation that improves efficiency, reduces risk, and supports consistent bioprocessing performance.